Trending

Delta surges, RateGain sinks: NSE's top 5 gainers & losers

The stocks that surged or fell the most on Tuesday (May 27, 2025)

The stocks that surged or fell the most on Tuesday (May 27, 2025)

While the broader market wilted on Tuesday (May 27, 2025), a bunch of mid- and small-cap stocks raced ahead - or crashed - on stock-specific triggers.

Below are the five biggest gainers and five worst losers on the NSE (National Stock Exchange), along with the reasons explaining their surge or decline.

Top 5 winners

Company Closing price (Rs) % change
Delta Manufacturing 96.6 20
Nupur Recyclers 84.5 20
Shriram Properties 97 14.7
Kronox Lab Sciences 168.6 13.8
Godavari Biorefineries 260 13.6

Top 5 losers

Company Closing price (Rs) % change
RateGain Travel Tech 473.0 -10.0
Cords Cable Industries 193.4 -9.5
Tracxn Technologies 57.0 -9.4
Parsvnath Developers 19.8 -7.1
Bajaj Healthcare 561.8 -6.8

The winners

#1 Delta Manufacturing

A micro-cap magnet maker, Delta Manufacturing hit the 20 per cent upper circuit on wafer-thin volumes. Price remains below its 52-week peak, but momentum traders piled in, betting on a turnaround.

Why it jumped

  • Micro-cap with limited float - small orders move the price quickly
  • Recent corporate action (September 2024) keeps speculative buzz alive
  • Rotation into niche industrial plays amid broad-market weakness

#2 Nupur Recyclers

Nupur Recyclers , a scrap-metal recycler, rebounded sharply after months of declines, closing just shy of the circuit filter.

Why it jumped

  • Bargain-hunting after the stock halved YoY
  • Main-board migration (March 2024) widened the investor pool
  • Street chatter of potential orders under India's green steel push

#3 Shriram Properties

Shriram Properties , a real estate developer, outperformed its peers after stellar quarterly numbers.

Why it jumped

  • Q4 FY25 profit up 137 per cent year-on-year (YoY); revenue up 19 per cent
  • Net debt down 26 per cent, easing balance-sheet worries
  • Management guides to a robust presales pipeline amid housing demand

#4 Kronox Lab Sciences

Kronox Lab Sciences, a specialty-chemical minnow, extended its post-earnings rally, nearing record highs.

Why it jumped

Q4 FY25 profit rose 7.5 per cent; annual profit up 19 per cent
Zero-debt balance sheet and an ROCE over 50 per cent attract quality-hunters
Low prior liquidity meant fresh buying propelled the price sharply

#5 Godavari Biorefineries

Godavari Biorefineries , an ethanol-and-sugar player logged a second straight upper-circuit day on upbeat outlook.

Why it jumped

  • Q4 profit up more than 10 per cent despite revenue dip; bio-chemicals EBITDA doubled
  • Announced capacity expansion for grain-based ethanol
  • Government's ethanol-blending mandate brightens long-term demand

The losers

#1 RateGain Travel Technologies

Travel-tech SaaS firm RateGain Travel Technologies skidded nearly 10 per cent after cautious commentary.

Why it fell

  • Q4 revenue grew only 1.9 per cent YoY, its slowest since listing
  • FY26 guidance trimmed; brokerages cut target prices
  • Profit-taking after a month-long rebound

#2 Cords Cable Industries

Specialty-cable maker Cords Cable Industries saw heavy profit-booking ahead of its fourth quarter results.

Why it fell

  • Traders braced for seasonally weak Q4 numbers
  • Stock had doubled in a year; valuation looked stretched
  • Low liquidity amplified stop-loss selling below Rs 200

#3 Tracxn Technologies

Data-platform provider Tracxn Technologies tumbled to near-record lows as losses resurfaced.

Why it fell

  • Swung to an Rs 8 crore loss in Q4 FY25 versus a Rs 1.4 crore profit during the same period last year
  • Revenue growth stuck in single digits; rising staff costs
  • Investors sceptical about the path back to profitability

#4 Parsvnath Developers

Parvsnath Developers , the debt-laden Delhi developer, continued its long slide.

Why it fell

  • Persistent quarterly losses and high leverage (around Rs 580 crore)
  • Asset-sale chatter yet to translate into cash flows
  • Rising rates erode the appeal of weaker realty names

#5 Bajaj Healthcare

API maker Bajaj Healthcare's shares reversed after an initial post-result spike.

Why it fell

  • Q4 EBITDA margin shrank to 7.6 per cent (-450 bps YoY)
  • Promoter stake dilution raises overhang concerns
  • Investors locked in gains after a 100 per cent rally over 12 months

Serious about wealth? So are we.

Join thousands of smart investors who rely on Value Research Stock Advisor for expert-picked stocks, time-tested strategies and long-term discipline.

Stop guessing. Start growing. Check it out now: Value Research Stock Advisor .

Disclaimer: This is not a stock recommendation. This story was created with the assistance of artificial intelligence and is intended for informational purposes only. Please take it with a pinch of salt and do your own research or consult a financial advisor before making investment decisions.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Other Categories